Breast Cancer Cell Apoptosis
Published: 9 Jan 2009
Views: 14484
Dr Anthony Letai, Assistant Professor of Medicine, Haematologic Malignancies, Dana-Farber Cancer Institute
Discusses how cells 'commit suicide' and breast cancer BCL2 inhibitor for taxol-resistant cancer
- Categories:
- Breast
- Haematology oncology
Related Videos
Long-term disease control in multiple myeloma by in-class transitioning: A commu...
Dr Robert Rifkin - Rocky Mountain Cancer Centers, Denver, USA
3 Jul 2020
Venetoclax plus navitoclax in R/R ALL and lymphoblastic lymphoma
Dr Elias Jabbour - MD Anderson Cancer Center, Houston, USA
3 Jul 2020
Treating acute lymphoblastic leukaemia in the era of COVID-19
Dr Elias Jabbour - MD Anderson Cancer Center, Houston, USA
3 Jul 2020
Managing acute myeloid leukaemia during the COVID-19 pandemic
Dr Naval Daver - MD Anderson Cancer Center, Houston, USA
1 Jul 2020
Gut microbiome disturbance by antibiotic treatment early in life is sufficient t...
Dr Carolina Vicente-Dueñas - Institute of Biomedical Research of Salamanca, Sala...
30 Jun 2020
Safety and efficacy of CD19/CD22 CAR T cells in children and young adults with r...
Dr Haneen Shalabi - National Cancer Institute, NIH, Bethesda, USA
30 Jun 2020
Using the novel antibody-drug conjugate, loncastuximab tesirine to treat patient...
Prof Carmelo Carlo-Stella - Humanitas Cancer Center, Milan, Italy
26 Jun 2020
Treating patients with multiple myeloma in the real world
Dr Ajai Chari and Prof Roman Hájek
26 Jun 2020
CDK6 a transcriptional regulator in AML
Prof Veronika Sexl - University of Veterinary Medicine of Vienna, Vienna, Austri...
27 Jun 2018
